Hospital Infantil Universitario Niño Jesús

Madrid, Madrid 28009

2 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Cancer Harboring BRAF Alterations, Eczema, HGG, LGG, Solid Tumors

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation